| Home > Publications Database > Prognostic impact of blood group O in MGMT-methylated glioblastoma patients receiving radiochemotherapy with temozolomide and lomustine. > Access to Fulltext |
DZNE-2026-00995
|
|||||||
| version 1 |
| ||||||